Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

ACC: Philips highlights hybrid OR

Philips Healthcare enjoyed a steady stream of curious cardiologists and cardiology personnel to its Hybrid OR Suite at the American College of Cardiology (ACC) meeting in Atlanta.

CCI: Bailout stenting feasible option for neonates with severe coarctation

Researchers have found that bailout stenting with a follow-up coarctectomy proved successful in premature infants who suffer from aortic coarctation, and can be performed with low rates of morbidity and complication, according to a study published in the March issue of Catheterization and Cardiovascular Interventions.

ACC: Is the jury still out on BMS vs. DES in STEMI patients?

ATLANTAMore research is needed on the relative costs and benefits of using drug-eluting stents (DES) versus bare-metal stents (BMS) in patients who have experienced a STEMI, according to the results of the DEDICATION trial presented Tuesday at the ACC.10 conference. Slides

ACC: St. Jude, Siemens partner to offer wireless FFR integration

St. Jude Medical announced during ACC.10 a new marketing agreement with Siemens Healthcare that will allow integrated wireless fractional flow reserve (FFR) measurement with PressureWire Aeris as an upgrade to hospitals using the Siemens Axiom Sensis XP hemodynamic recording system.

ACC: Boston Scientific combines CV and rhythm divisions

Boston Scientific has a new cardiac rhythm and vascular (CRV) business unit, which is the combination of its cardiovascular and cardiac rhythm management divisions. The Natick, Mass.-based company highlighted the change at the recent American College of Cardiology (ACC) conference in Atlanta.

ACC: Enrollment complete for Promus Element small vessel/long lesion trials

Boston Scientific announced the completion of patient enrollment in the small vessel and long lesion trials of its PLATINUM clinical program during the American College of Cardiology (ACC) conference in Atlanta this week. The trials are designed to compare the platinum chromium Promus Element everolimus-eluting stent to matched historical control groups of patients treated with the Taxus Express paclitaxel-eluting stent.

ACC Feature: Saphenous vein grafts appear equal to radial artery grafts

ATLANTA--Saphenous vein grafts and radial artery grafts both result in equal graft opening at one year, according to a study presented as a late-breaking clinical trial Tuesday at the American College of Cardiologys (ACC) 59th annual scientific session. Slides

CRF/ACC: Xience is economically dominant to Taxus

ATLANTAAt one-year in the SPIRIT IV trial, the use of Abbotts Xience V stent was an economically dominant strategy compared with Boston Scientifics Taxus stent with improved clinical outcomes and lower overall medical costs, according to the interim results of an analysis presented Saturday during CRF's Optimizing PCI Outcomes Symposium, which ran concurrent to the American College of Cardiology (ACC) conference. Slides

Displaying 2481 - 2488 of 2683

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.